Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tuberculosis infection prevention by quick testing

28.09.2005


With a new DNA test, tuberculosis infection can be revealed so quickly that a patient doesn’t have time to infect others. This can be an important key to effective control of the disease.



The Norwegian biotechnology firm Genpoint is running trials, along with others financed by the Norwegian Research Council’s biotechnology program, of new and effective DNA tests at Ullevål University Hospital, the country’s national laboratory for tuberculosis.

Norwegian health officials calculate that a person infected with tuberculosis, with today’s diagnosis methods, can infect on average 20 others before the disease is detected and the patient can be isolated and treated.


The current manual test methods take at least a week, and the bacteria must incubate for up to eight weeks before an precise diagnosis can be made. This is a comprehensive process for both the patient and the laboratories that perform the tests. In addition, the tests must often be taken several times over a period of up to six months before it is certain what type of tuberculosis bacteria is being dealt with.

Genpoint’s automated DNA method simplifies diagnostics and provides test results that are available in a few minutes at best and in a few hours at worst. Therefore health personnel are able to test much larger groups, gaining much better and more effective control of the disease and its transmission.

The test methods are approved in the sense that Genpoint is in the process of fulfilling the requirements for documentation that have been set by the hospital laboratory in close co-operation with experts in the hospital milieu.

-We expect to be finished with the documentation period late this autumn and that the tests in the best case can be available for ordinary use in the country’s laboratories from late autumn or early next year, explains Genpoint’s Administrative Director Geir Gogstad.

The new test methods will mean an enormous difference from the existing test when it comes to the authorities’ ability to treat tuberculosis patients.

-Many more can be tested using far less money than today, without an increase of personnel in the health care sector”, says Gogstad.

Magic spheres

Genpoint makes use of magic spheres to isolate bacteria and holds a world-wide patent for the process. The spheres pull bacteria to themselves, and then dissolve the bacteria so that the DNA is released and absorbed by the spheres. With further analysis of the DNA, the bacteria can be identified. Both the cells and the DNA are captured by the same sphere surface, making it much easier to automate the process.

Genpoint operates in the global market with its products. New forms of tuberculosis bacteria are constantly being discovered, or so called mycobacteria, which tuberculosis-related bacteria. Many of these are resistant to antibiotics. Therefore the job to find more effective and speedy methods to identify the disease and reduce infection are more important than ever before, even though the disease over the last 40 years has been held in check in northern Europe thanks to vaccination programmes.

In the next round, Genpoint plans to further develop its tests to include multi-resistant staphylococcus, which is a world-wide problem in hospitals, but has begun to manifest itself as a contagion outside of hospitals. In this case, a quick and reliable method for identifying the oganism and beginning treatment is even more crucial because the staphylococcus is very resistant to antibiotics.

Elisabeth Kirkeng Andersen | alfa
Further information:
http://www.genpoint.no

More articles from Life Sciences:

nachricht Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)

nachricht CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>